Trial Profile
Use of Prothrombin complex concentrate to reverse the effect of apixaban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Prothrombin complex concentrate
- Indications Acute coronary syndromes; Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Pharmacokinetics; Therapeutic Use
- 19 Dec 2015 New trial record